Release Date: 30/04/20 19:24 Summary: March 2020 Quarterly Report & Appendix 5B Price Sensitive: Yes Download Document 419.12KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%